The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGR.L Regulatory News (MGR)

  • There is currently no data for MGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Share Buyback

11 Dec 2018 07:00

RNS Number : 0334K
Miton Group Plc
11 December 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR

INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

 

11 December 2018

Miton Group plc

Proposed Share Buyback

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 ('MAR'). 

 

Miton Group plc (the "Company" or "Group"), the AIM quoted fund management group, today announces that the Group has instructed Liberum Capital Limited ("Liberum") to acquire up to 5,502,180 ordinary shares of 0.1p each in the Company ("Ordinary Shares") on 13 December 2018 in order to reduce the dilution from the shares recently issued to participants of the Growth Share Plan (the "Proposed Share Buyback"). Any Ordinary Shares purchased under the Proposed Share Buyback will be cancelled.

Shareholders who want to participate in the Proposed Share Buyback are requested to contact Liberum on the contact details below as soon as possible and by no later than 3.00 p.m. on 12 December 2018:

Steve Keeling (Sales):

020 3100 2120

Graham Smith (Head of Execution):

020 3100 2101

Mark O'Hara (Sales Trading):

020 3100 2061

 

Terms of the Proposed Share Buyback

Liberum will carry out a bookbuild process to determine the price at which the Ordinary Shares may be purchased by the Company.

Any purchases of Ordinary Shares by the Company in relation to this announcement will be carried out on the London Stock Exchange and will be effected within certain pre-set parameters and in accordance with (and subject to) the limits prescribed by the general authority to purchase shares granted by the Company's shareholders at the 2018 Annual General Meeting held on 8 May 2018. The maximum price at which the Company can purchase shares will be the higher of (i) 105% of the average mid-market close price for the five business days up to and including 12 December 2018, (ii) the last independent trade on 12 December 2018, and (iii) the highest independent bid on the London Stock Exchange at market close on 12 December 2018. The minimum price of the Proposed Share Buyback will be 100% of the average mid-market close price for the five business days up to and including 12 December 2018.

Once applications to participate in the Proposed Share Buyback are made to Liberum, such requests shall be irrevocably binding. The Company intends that shareholders will be able to participate in the Proposed Share Buyback pro rata to their current holdings of Ordinary Shares. Notwithstanding the above, requests to participate in the Proposed Share Buyback may be subject to scaling back at the absolute discretion of the Company and Liberum.

The Proposed Share Buyback is expected to exceed the 25% limit of the average daily trading volume as laid down in Article 3 of Commission Delegated Regulation (EU) No 2016/1052.

There can be no certainty that the Company will purchase any Ordinary Shares under the Proposed Share Buyback.

Proposed PDMR Dealing

The Company has been notified by Gervais Williams, an Executive Director, of his intention to sell up to 2,500,000 Ordinary Shares in the Proposed Share Buyback.

Expected Timetable of Events

Announcement of Proposed Share Buyback

11 December 2018

Books Close

3.00 p.m. on 12 December 2018

Announcement of Result of Share Buyback

13 December 2018

 

*All times shown are London times unless otherwise stated. The dates and times given are indicative only and are based on the Company's current expectations and may be subject to change. If any of the times and/or dates above change, the revised times and/or dates will be notified to Shareholders by announcement through the Regulatory News Service of the London Stock Exchange.

 

Assets under Management

As at 30 November 2018 the Group's unaudited Assets under Management ('AuM') were £4,611 million.

Total Voting Rights

The Company's issued share capital prior to the Proposed Share Buyback comprises 178,137,591 Ordinary Shares. The Company holds nil Ordinary Shares in Treasury. Therefore the total voting rights of the Company are 178,137,591 Ordinary Shares and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The person responsible for releasing this announcement on behalf of Miton Group plc is Catriona Fletcher, Company Secretary.

LEI number: 2138004UNDYXLICL8H10

Liberum is acting only for the Company in connection with the matters described in this announcement. Liberum is not acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Liberum or advice to any other person in relation to the matters contained herein.

 

For further information, please contact:

Miton Group plc

David Barron (CEO) / Catriona Fletcher (Company Secretary)

 

 

020 3714 1500

Liberum (Nominated Adviser and Joint Broker)

Neil Patel / Cameron Duncan

 

 

020 3100 2000

N+1 Singer (Joint Broker)

Tom Salvesen

 

 

020 7496 3000

 

www.mitongroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSGGGMCPUPRGMU
Date   Source Headline
10th Nov 201711:01 amRNSHolding(s) in Company
6th Nov 20175:18 pmRNSHolding(s) in Company
1st Nov 201712:20 pmPRNForm 8.3 - Clinigen Group Plc
31st Oct 20178:06 amRNSDirector dealings
26th Oct 20174:53 pmRNSHolding(s) in Company
25th Oct 201711:23 amRNSDirector dealings
23rd Oct 201710:24 amPRNForm 8.3 - Belvoir Lettings Plc
23rd Oct 201710:12 amPRNForm 8.3 - Property Franchise Group PLC
19th Oct 20174:43 pmRNSHolding(s) in Company
19th Oct 20172:53 pmRNSHolding(s) in Company
19th Oct 20171:54 pmRNSHolding(s) in Company
18th Oct 20179:37 amRNSExchange of shares under the Growth Share Plan
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20171:20 pmRNSHolding(s) in Company
27th Sep 20172:54 pmRNSHolding(s) in Company
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 201712:05 pmRNSHolding(s) in Company
21st Sep 20173:31 pmRNSDirector dealings
21st Sep 20179:33 amRNSHolding(s) in Company
21st Sep 20177:01 amRNSHalf-year Report
21st Sep 20177:00 amRNSDirectorate Change
20th Sep 201710:15 amRNSHolding(s) in Company
15th Sep 20172:00 pmRNSHolding(s) in Company
15th Sep 20179:39 amRNSHolding(s) in Company
14th Sep 20174:10 pmRNSHolding(s) in Company
11th Sep 20179:56 amPRNForm 8.3 - Novae Group Plc
8th Sep 20175:00 pmRNSHolding(s) in Company
7th Sep 20172:21 pmRNSHolding(s) in Company
6th Sep 20177:00 amRNSHolding(s) in Company
4th Sep 201712:07 pmRNSHolding(s) in Company
1st Sep 20173:44 pmRNSHolding(s) in Company
1st Sep 20173:28 pmRNSHolding(s) in Company
30th Aug 20175:18 pmRNSHolding(s) in Company
30th Aug 20174:09 pmRNSDirector/PDMR Shareholding
24th Aug 20173:55 pmRNSTR-1: Notification of Major Interest in Shares
22nd Aug 201712:04 pmRNSHolding(s) in Company
18th Aug 201710:10 amRNSHolding(s) in Company
17th Aug 20174:06 pmPRNForm 8 (OPD) Quantum Pharma Plc
17th Aug 201711:23 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSHolding(s) in Company
9th Aug 201712:40 pmRNSHolding(s) in Company
3rd Aug 20178:42 amRNSTR1 - Notification of Major Holdings
28th Jul 20178:25 amRNSHolding(s) in Company
27th Jul 20175:36 pmRNSDirector dealings
24th Jul 20172:05 pmRNSHolding(s) in Company
20th Jul 20174:55 pmRNSHolding(s) in Company
19th Jul 20175:16 pmRNSHolding(s) in Company
12th Jul 201711:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.